{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:03:39Z","timestamp":1790964219606,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T00:00:00Z","timestamp":1509408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T00:00:00Z","timestamp":1509408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We report here the sequence and functional characterization of a recombinantly expressed autoantibody (mAb 131) previously isolated from a myasthenia gravis patient by immortalization of thymic B cells using Epstein-Barr virus and TLR9 activation. The antibody is characterized by a high degree of somatic mutations as well as a 6 amino acid insertion within the VHCDR2. The recombinant mAb 131 is specific for the \u03b3-subunit of the fetal AChR to which it bound with sub-nanomolar apparent affinity, and detected the presence of fetal AChR on a number of rhabdomyosarcoma cell lines. Mab 131 blocked one of the two \u03b1-bungarotoxin binding sites on the fetal AChR, and partially blocked the binding of an antibody (mAb 637) to the \u03b1-subunit of the AChR, suggesting that both antibodies bind at or near one ACh binding site at the \u03b1\/\u03b3 subunit interface. However, mAb 131 did not reduce fetal AChR ion channel currents in electrophysiological experiments. These results indicate that mAb 131, although generated from an MG patient, is unlikely to be pathogenic and may make it a potentially useful reagent for studies of myasthenia gravis, rhabdomyosarcoma and arthrogryposis multiplex congenita which can be caused by fetal-specific AChR-blocking autoantibodies.<\/jats:p>","DOI":"10.1038\/s41598-017-14350-8","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T10:11:51Z","timestamp":1508926311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient"],"prefix":"10.1038","volume":"7","author":[{"given":"Abhishek","family":"Saxena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5737-7325","authenticated-orcid":false,"given":"Jo","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Koneczny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Lazaridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socrates","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Vrolix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Nogales-Gadea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbie","family":"Machiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Molenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Damoiseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc H.","family":"De Baets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Simon-Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-0002","authenticated-orcid":false,"given":"Mario","family":"Losen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Martinez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,31]]},"reference":[{"key":"14350_CR1","first-page":"1054","volume":"26","author":"JM Lindstrom","year":"1976","unstructured":"Lindstrom, J. M., Seybold, M. E., Lennon, V. A., Whittingham, S. & Duane, D. D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 26, 1054\u20131059 (1976).","journal-title":"Prevalence, clinical correlates, and diagnostic value. Neurology"},{"key":"14350_CR2","doi-asserted-by":"publisher","unstructured":"Phillips, W. D. & Vincent, A. Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms. F1000Research 5(F1000 Faculty Rev), 1513, https:\/\/doi.org\/10.12688\/f1000research.8206.1 (2016).","DOI":"10.12688\/f1000research.8206.1"},{"key":"14350_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJM197701202960301","volume":"296","author":"KV Toyka","year":"1977","unstructured":"Toyka, K. V. et al. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med. 296, 125\u2013131, https:\/\/doi.org\/10.1056\/NEJM197701202960301 (1977).","journal-title":"Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med."},{"key":"14350_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/eji.1830080808","volume":"8","author":"H Wekerle","year":"1978","unstructured":"Wekerle, H., Ketelsen, U. P., Zurn, A. D. & Fulpius, B. W. Intrathymic pathogenesis of myasthenia gravis: transient expression of acetylcholine receptors on thymus-derived myogenic cells. Eur J Immunol. 8, 579\u2013582, https:\/\/doi.org\/10.1002\/eji.1830080808 (1978).","journal-title":"Eur J Immunol."},{"key":"14350_CR5","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.4049\/jimmunol.157.8.3752","volume":"157","author":"A Wakkach","year":"1996","unstructured":"Wakkach, A. et al. Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis. J Immunol. 157, 3752\u20133760 (1996).","journal-title":"J Immunol."},{"key":"14350_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/1096-9926(200011)62:5<332::AID-TERA7>3.0.CO;2-E","volume":"62","author":"A Polizzi","year":"2000","unstructured":"Polizzi, A., Huson, S. M. & Vincent, A. Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis. Teratology. 62, 332\u2013341, https:\/\/doi.org\/10.1002\/1096-9926(200011)62:5\u2009<\u2009332::AID-TERA7\u2009>\u20093.0.CO;2-E (2000).","journal-title":"Teratology."},{"key":"14350_CR7","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/01.LAB.0000032379.63784.9C","volume":"82","author":"I Matthews","year":"2002","unstructured":"Matthews, I. et al. Antibodies to acetylcholine receptor in parous women with myasthenia: evidence for immunization by fetal antigen. Lab Invest. 82, 1407\u20131417 (2002).","journal-title":"Lab Invest."},{"key":"14350_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3109\/08916930903555943","volume":"43","author":"AM Gomez","year":"2010","unstructured":"Gomez, A. M. et al. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction. Autoimmunity 43, 353\u2013370, https:\/\/doi.org\/10.3109\/08916930903555943 (2010).","journal-title":"Autoimmunity"},{"key":"14350_CR9","first-page":"82","volume":"67","author":"A Rodgaard","year":"1987","unstructured":"Rodgaard, A., Nielsen, F. C., Djurup, R., Somnier, F. & Gammeltoft, S. Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3. Clinical and experimental immunology 67, 82\u201388 (1987).","journal-title":"Clinical and experimental immunology"},{"key":"14350_CR10","first-page":"267","volume":"52","author":"AG Engel","year":"1977","unstructured":"Engel, A. G., Lambert, E. H. & Howard, F. M. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clinic proceedings 52, 267\u2013280 (1977).","journal-title":"Mayo Clinic proceedings"},{"key":"14350_CR11","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.nmd.2012.01.002","volume":"22","author":"A D\u2019Amico","year":"2012","unstructured":"D\u2019Amico, A. et al. Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis: a case report. Neuromuscular disorders: NMD 22, 546\u2013548, https:\/\/doi.org\/10.1016\/j.nmd.2012.01.002 (2012).","journal-title":"Neuromuscular disorders: NMD"},{"key":"14350_CR12","doi-asserted-by":"publisher","unstructured":"Hacohen, Y. et al. Fetal acetylcholine receptor inactivation syndrome: A myopathy due to maternal antibodies. Neurology(R) neuroimmunology & neuroinflammation 2, e57, https:\/\/doi.org\/10.1212\/NXI.0000000000000057 (2015).","DOI":"10.1212\/NXI.0000000000000057"},{"key":"14350_CR13","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1172\/JCI5943","volume":"103","author":"L Jacobson","year":"1999","unstructured":"Jacobson, L., Polizzi, A., Morriss-Kay, G. & Vincent, A. Plasma from human mothers of fetuses with severe arthrogryposis multiplex congenita causes deformities in mice. J Clin Invest. 103, 1031\u20131038, https:\/\/doi.org\/10.1172\/JCI5943 (1999).","journal-title":"J Clin Invest."},{"key":"14350_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0140-6736(95)92652-6","volume":"346","author":"A Vincent","year":"1995","unstructured":"Vincent, A. et al. Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet 346, 24\u201325, https:\/\/doi.org\/10.1016\/S0140-6736(95)92652-6 (1995).","journal-title":"Lancet"},{"key":"14350_CR15","first-page":"437","volume":"152","author":"S Gattenloehner","year":"1998","unstructured":"Gattenloehner, S. et al. The fetal form of the acetylcholine receptor distinguishes rhabdomyosarcomas from other childhood tumors. Am J Pathol. 152, 437\u2013444 (1998).","journal-title":"Am J Pathol."},{"key":"14350_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.bbmt.2009.11.020","volume":"16","author":"PJ Stiff","year":"2010","unstructured":"Stiff, P. J. et al. Highdose chemotherapy with blood or bone marrow transplants for rhabdomyosarcoma. Biol Blood Marrow Transplant. 16, 525\u2013532, https:\/\/doi.org\/10.1016\/j.bbmt.2009.11.020. (2010).","journal-title":"Biol Blood Marrow Transplant."},{"key":"14350_CR17","doi-asserted-by":"publisher","first-page":"187621","DOI":"10.1155\/2010\/187621","volume":"2010","author":"S Gattenl\u00f6hner","year":"2010","unstructured":"Gattenl\u00f6hner, S. et al. A Human Recombinant Autoantibody-Based Immunotoxin Specific for the Fetal Acetylcholine Receptor Inhibits Rhabdomyosarcoma Growth In Vitro and in a Murine Transplantation Model. Journal of Biomedicine and Biotechnology. 2010, 187621, https:\/\/doi.org\/10.1155\/2010\/187621 (2010).","journal-title":"Journal of Biomedicine and Biotechnology."},{"key":"14350_CR18","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.4049\/jimmunol.1301555","volume":"193","author":"AM Gomez","year":"2014","unstructured":"Gomez, A. M. et al. Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients. J Immunol. 193, 1055\u20131063, https:\/\/doi.org\/10.4049\/jimmunol.1301555 (2014).","journal-title":"J Immunol."},{"key":"14350_CR19","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1172\/JCI113401","volume":"81","author":"A Melms","year":"1988","unstructured":"Melms, A. et al. Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J Clin Invest. 81, 902\u2013908, https:\/\/doi.org\/10.1172\/JCI113401 (1988).","journal-title":"J Clin Invest."},{"key":"14350_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jaut.2013.12.008","volume":"52","author":"K Vrolix","year":"2014","unstructured":"Vrolix, K. et al. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor. J Autoimmu. 52, 101\u2013112, https:\/\/doi.org\/10.1016\/j.jaut.2013.12.008. (2014).","journal-title":"J Autoimmu."},{"key":"14350_CR21","doi-asserted-by":"publisher","first-page":"e52830","DOI":"10.3791\/52830","volume":"100","author":"G Nogales-Gadea","year":"2015","unstructured":"Nogales-Gadea, G. et al. Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells. J Vis Exp 100, e52830, https:\/\/doi.org\/10.3791\/52830 (2015).","journal-title":"J Vis Exp"},{"key":"14350_CR22","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/intimm\/9.9.1311","volume":"9","author":"J Farrar","year":"1997","unstructured":"Farrar, J. et al. Diverse Fab specific for acetylcholine receptor epitopes from a myasthenia gravis thymus combinatorial library. Int Immunol. 9, 1311\u20131318, https:\/\/doi.org\/10.1093\/intimm\/9.9.1311 (1997).","journal-title":"Int Immunol."},{"key":"14350_CR23","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/eji.200425671","volume":"35","author":"E Fostieri","year":"2005","unstructured":"Fostieri, E., Tzartos, S. J., Berrih-Aknin, S., Beeson, D. & Mamalaki, A. Isolation of potent human Fab fragments against a novel highly immunogenic region on human muscle acetylcholine receptor which protect the receptor from myasthenic autoantibodies. Eur J Immunol. 35, 632\u2013643, https:\/\/doi.org\/10.1002\/eji.200425671 (2005).","journal-title":"Eur J Immunol."},{"key":"14350_CR24","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4049\/jimmunol.158.4.1919","volume":"158","author":"YF Graus","year":"1997","unstructured":"Graus, Y. F. et al. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies. J Immunol. 158, 1919\u20131929 (1997).","journal-title":"J Immunol."},{"key":"14350_CR25","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.4049\/jimmunol.167.4.1935","volume":"167","author":"GP Sims","year":"2001","unstructured":"Sims, G. P., Shiono, H., Willcox, N. & Stott, D. I. Somatic hypermutation and selection of B cells in thymic germinal centers responding toacetylcholine receptor in myasthenia gravis. J Immunol. 167, 1935\u20131944, https:\/\/doi.org\/10.4049\/jimmunol.167.4.1935 (2001).","journal-title":"J Immunol."},{"key":"14350_CR26","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1172\/JCI119048","volume":"98","author":"S Riemersma","year":"1996","unstructured":"Riemersma, S. et al. Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. J Clin Invest 98, 2358\u20132363, https:\/\/doi.org\/10.1172\/JCI119048 (1996).","journal-title":"J Clin Invest"},{"key":"14350_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/00019606-199806000-00001","volume":"7","author":"S Gattenloehner","year":"1998","unstructured":"Gattenloehner, S., M\u00fcller-Hermelink, H. K. & Marx, A. Polymerase chain reaction-based diagnosis of rhabdomyosarcomas: comparison of fetal type acetylcholine receptor subunits and myogenin. Diagn Mol Pathol. 7, 129\u2013134 (1998).","journal-title":"Diagn Mol Pathol."},{"key":"14350_CR28","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1073\/pnas.74.7.3090","volume":"74","author":"S Heinemann","year":"1977","unstructured":"Heinemann, S., Bevan, S., Kullberg, R., Lindstrom, J. & Rice, J. Modulation of acetylcholine receptor by antibody against the receptor. Proc Natl Acad Sci USA 74, 3090\u20133094 (1977).","journal-title":"Proc Natl Acad Sci USA"},{"key":"14350_CR29","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1126\/science.850793","volume":"196","author":"I Kao","year":"1977","unstructured":"Kao, I. & Drachman, D. Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. Science. 196, 527\u2013529, https:\/\/doi.org\/10.1126\/science.850793 (1977).","journal-title":"Science."},{"key":"14350_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01019-5","volume":"7","author":"M Losen","year":"2017","unstructured":"Losen, M. et al. Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys. Scientific Reports 7, 992, https:\/\/doi.org\/10.1038\/s41598-017-01019-5 (2017).","journal-title":"Scientific Reports"},{"key":"14350_CR31","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1073\/pnas.77.7.4326","volume":"77","author":"B Fulpius","year":"1980","unstructured":"Fulpius, B., Miskin, R. & Reich, E. Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors. Proc Natl Acad Sci USA 77, 4326\u20134330 (1980).","journal-title":"Proc Natl Acad Sci USA"},{"key":"14350_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0014-5793(86)80220-4","volume":"196","author":"SJ Tzartos","year":"1986","unstructured":"Tzartos, S. J. & Starzinski-Powitz, A. Decrease in acetylcholine-receptor content of human myotube cultures mediated by monoclonal antibodies to alpha, beta and gamma subunits. FEBS letters 196, 91\u201395 (1986).","journal-title":"FEBS letters"},{"key":"14350_CR33","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1126\/science.1144603","volume":"317","author":"M van der Neut Kolfschoten","year":"2007","unstructured":"van der Neut Kolfschoten, M. et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 317, 1554\u20131557, https:\/\/doi.org\/10.1126\/science.1144603 (2007).","journal-title":"Science"},{"key":"14350_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2016.11.005","volume":"77","author":"I Koneczny","year":"2017","unstructured":"Koneczny, I. et al. IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients. J Autoimmun. 77, 104\u2013115, https:\/\/doi.org\/10.1016\/j.jaut.2016.11.005 (2017).","journal-title":"J Autoimmun."},{"key":"14350_CR35","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1046\/j.1365-2249.2003.02026.x","volume":"131","author":"M Behrendt","year":"2003","unstructured":"Behrendt, M. et al. The role of somatic mutation in determining the affinity of anti-DNA antibodies. Clin Exp Immunol. 131, 182\u2013189 (2003).","journal-title":"Clin Exp Immunol."},{"key":"14350_CR36","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.4049\/jimmunol.161.6.2895","volume":"161","author":"W Ikematsu","year":"1998","unstructured":"Ikematsu, W., Kobarg, J., Ikematsu, H., Ichiyoshi, Y. & Casali, P. Clonal analysis of a human antibody response. III. Nucleotide sequences of monoclonal IgM, IgG, and IgA to rabies virus reveal restricted V kappa gene utilization, junctional V kappa J kappa and V lambda J lambda diversity, and somatic hypermutation. J Immunol. 161, 2895\u20132905 (1998).","journal-title":"J Immunol."},{"key":"14350_CR37","first-page":"130","volume":"68","author":"b Vernet-der Garabedian","year":"1987","unstructured":"Vernet-der Garabedian, b, Bach, J. F. & Morel, E. Protective effect of myasthenic immunoglobulins against the lethal toxicity of alpha bungarotoxin. Clin Exp Immunol. 68, 130\u2013137 (1987).","journal-title":"Clin Exp Immunol."},{"key":"14350_CR38","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1212\/WNL.33.10.1316","volume":"33","author":"UA Besinger","year":"1983","unstructured":"Besinger, U. A. et al. Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology. 33, 1316\u20131321 (1983).","journal-title":"Neurology."},{"key":"14350_CR39","first-page":"537","volume":"51","author":"W Molina","year":"2010","unstructured":"Molina, W., Reyes, E., Joshi, N., Barrios, A. & Hernandez, L. Maturation of the neuromuscular junction in masseters of human fetus. Rom J Morphol Embryol 51, 537\u2013541 (2010).","journal-title":"Rom J Morphol Embryol"},{"key":"14350_CR40","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.molimm.2011.04.011","volume":"48","author":"G Girardi","year":"2011","unstructured":"Girardi, G., Prohaszka, Z., Bulla, R., Tedesco, F. & Scherjon, S. Complement activation in animal and human pregnancies as a model for immunological recognition. Mol Immunol 48, 1621\u20131630, https:\/\/doi.org\/10.1016\/j.molimm.2011.04.011 (2011).","journal-title":"Mol Immunol"},{"key":"14350_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/jcp.45.1.66","volume":"45","author":"ND Hopkins","year":"1992","unstructured":"Hopkins, N. D. & Powell, R. J. Classical complement activation induced by pregnancy: implications for management of connective tissue diseases. J Clin Pathol 45, 66\u201367 (1992).","journal-title":"J Clin Pathol"},{"key":"14350_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/14767050500072722","volume":"17","author":"K Richani","year":"2005","unstructured":"Richani, K. et al. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med 17, 239\u2013245 (2005).","journal-title":"J Matern Fetal Neonatal Med"},{"key":"14350_CR43","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/path.2893","volume":"225","author":"D Cohen","year":"2011","unstructured":"Cohen, D. et al. Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss. J Pathol 225, 502\u2013511, https:\/\/doi.org\/10.1002\/path.2893 (2011).","journal-title":"J Pathol"},{"key":"14350_CR44","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ijbiomac.2013.11.003","volume":"63","author":"K Lazaridis","year":"2014","unstructured":"Lazaridis, K. et al. Expression of human AChR extracellular domain mutants with improved characteristics. Int J Biol Macromol. 63, 210\u2013217, https:\/\/doi.org\/10.1016\/j.ijbiomac.2013.11.003 (2014).","journal-title":"Int J Biol Macromol."},{"key":"14350_CR45","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1073\/pnas.1220145110","volume":"110","author":"AF Labrijn","year":"2013","unstructured":"Labrijn, A. F. et al. Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange. Proc Natl Acad Sci USA 110, 5145\u20135150, https:\/\/doi.org\/10.1073\/pnas.1220145110 (2013).","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14350-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14350-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14350-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T14:50:29Z","timestamp":1693147829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14350-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,31]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["14350"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-14350-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,31]]},"assertion":[{"value":"21 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14426"}}